PUMA Womens Deva Reptile Casual Sneakers, Clothing, Shoes & Jewelry

PUMA Womens Deva Reptile Casual Sneakers, Clothing, Shoes & Jewelry

PUMA Womens Deva Reptile Casual Sneakers, Clothing, Shoes & Jewelry

PUMA Womens Deva Reptile Casual Sneakers

PUMA Womens Deva Reptile Casual SneakersClothing, Shoes & Jewelry Women Shoes Fashion Sneakers PUMA Womens Deva Reptile Casual Sneakers, Clothing, Shoes & Jewelry USA fabric-and-synthetic
Made in or Imported

PUMA Womens Deva Reptile Casual Sneakers, Clothing, Shoes & Jewelry

USA fabric-and-synthetic
Made in or Imported

MTM Survivor Dry Box with O-Ring Seal YellowMaps Great Bend KS topo map 1100000 Scale 30 X 60 Minute Historical 1985 Updated 1985 24.55 x 41 in DDZJ 10Pcs Transparent Keyboard ABS Matte Keycaps Mechanical Keyboard Backlit Keycaps for Cherry MX Axis Mechanical KeyboardR4 Ambesonne Nature Coverlet Rock Formations in Bryce Canyon National Park from Utah Picture 3 Piece Decorative Quilted Bedspread Set with 2 Pillow Shams Queen Size Sea Blue and Persian Orange adidas womens Adidas Womens Training Performer Baseline 1/4 Zip Long Sleeve Top So Danca Womens Ankle Strap Ballet Flats AC 400V DZ47-63 Air Switch Circuit Breaker Miniature Leakage Protection for Solar Energy and Small Power Generation System50A 3 Colors 3.2M Wall Sealing Strip Self Adhesive Bath Waterproof Sealing Strip Sink Basin Edge Trim for Kitchen Bathroom22mm3.2M-Grey iWoo Mens Cotton Linen Drawstring Pants Elastic Waist Casual Jogger Yoga Pants 14k Rhodium-Plated Diamond Cut Diagonal Swirl Charm for Women

Accelerating Cancer Research

Placing the patient at the center of cancer care



Gateway for Cancer Research accelerates practice-changing clinical trials to cancer research by harnessing the unrelenting passion of the research community and empowering patients to triumph over their disease. All of this is guided by a clear vision: To shape a world in which a cancer diagnosis is no longer feared.

For Researchers

Explore Gateway’s cutting-edge cancer research program

Gateway Impact

Learn more about Gateway for Cancer Research and our critical mission

For Supporters

Donate to cancer research today and help advance lifesaving cancer research


Our most prestigious giving level, Gateway Concierge is a dynamic ecosystem that allows forward-thinking philanthropists to co-create new possibilities in cancer care. Gateway will connect global benefactors with world-class clinician-scientists to create a research program that will deliver results in the fight against cancer—enabling real human impact now.

Get Started


Read about the unwavering patients and the cancer researchers who are helping us put and end to cancer as we know it.

Patient Profile: Kent

Kent enrolled in a Gateway-funded cancer research trial to treat his acute myeloid leukemia. See what he and his doctor had to say about his experience in this trial.

Watch Kent’s Story

Gateway’s Impact

9,000+ patients have been impacted by Gateway for Cancer Research funded clinical trials to date.


ASCO Connection

Improving Health Equity Together: A Conversation with Maria Rubinstein, Sameek Roychowdhury, and Mary Lou Smith

Read the Article

“Never again am I going to look at a birthday and say, ‘I can’t believe I’m going to be another year older.’ Now I’m saying, ‘I’m so glad to be another year older!’”

- Beth, lymphoma patient in a Gateway-funded trial

Why Give to Gateway

99 cents of every dollar donated to Gateway goes directly towards funding a cancer clinical trial.


Gateway Supports European Organisation for Research and Treatment of Cancer Grant

Read More

Did You Know?

190+ clinical trials have been funded worldwide by Gateway for Cancer Research since 1991.

View Our Clinical Trials


Gateway for Cancer Research only invests in Phase I and Phase II human clinical trials where true innovation and transformational discoveries happen.

Trial Type: Lung Cancer

Identification of Predictive Biomarkers to Prevent Pneumonitis in Patients with Non-Small Cell Lung Cancer Who are Receiving Immunotherapy (Phase II)

Ajay Sheshadri, MD
The University of Texas MD Anderson Cancer Center

Read More

Trial Type: Pancreatic Cancer

Novel Use of Pepinemab in Combination with Nivolumab and FOLFIRINOX Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma (Phase Ib/II)

David Linehan, MD
University of Rochester

Read More

Extraordinary Times Call for Extraordinary Measures

COVID-19 significantly disrupted patient access to clinical trials—research that can make a world of difference for those facing cancer. In response to this long-term trend, Gateway launched an innovative new funding program to support “decentralized” clinical studies that bring trials to the doorsteps of cancer patients by leveraging technology and at-home care.

Extraordinary Measures, an urgent new fundraising campaign unlike any we have ever conducted in our nearly 30-year history, will advance this new grant program, helping to ensure all those facing cancer continue to receive potentially lifesaving therapies.

Read More

Fund One Day

It costs just $16.56 per patient per day in a Gateway-funded cancer clinical trial.

Help us fund another day of research, another week or more. You can even mark your gift with a special date, such as an anniverary, birthday, wedding, bar/bat mitzvah or graduation.